Search Within

Sergio Andres Giralt

Formats
  1. Meeting Abstract (642)
  2. Journal Article (376)
  3. Research Letter (20)
  4. Review (15)
  5. Guidelines (5)
  6. Correspondence (4)
  7. Editorial (4)
  8. Book Section (3)
Groups
  1. Bone Marrow Transplant (1069)
  2. Center for Hematologic Malignancies (1069)
  3. Department of Medicine (1069)
  4. Hematologic Malignancies, Division of (1069)
  5. Survivorship Research (703)
  6. CTCR Scholars (557)

More Groups

People
  1. Miguel-Angel Perales (429)
  2. Sean Devlin (380)
  3. Gunjan Shah (311)
  4. Michael Scordo (279)
  5. Heather Landau (263)
  6. Ann Jakubowski (242)

More People

Years
  1. 2025 (18)
  2. 2024 (65)
  3. 2023 (104)
  4. 2022 (77)
  5. 2021 (66)
  6. 2020 (91)

More Years

Publications
  1. Blood (314)
  2. Biology of Blood and Marrow Transplantation (275)
  3. Bone Marrow Transplantation (80)
  4. Clinical Lymphoma, Myeloma and Leukemia (60)
  5. Journal of Clinical Oncology (40)
  6. Transplantation and Cellular Therapy (36)

More Publications

Publishers
  1. Elsevier Inc. (386)
  2. American Society of Hematology (349)
  3. Nature Publishing Group (110)
  4. American Society of Clinical Oncology (42)
  5. Taylor & Francis Group (35)
  6. Ferrata Storti Foundation (13)

More Publishers

Results (1069)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High day 28 ST2 biomarker levels predict severe day 100 acute graft-versus-host disease and day 180 transplant-related mortality after double-unit cord blood transplantation
    Meeting Abstract

    Ponce, D. M.; Hilden, P.; Mumaw, C.; Devlin, S.; Lubin, M.; Evans, K.; Prockop, S. E.; Scaradavou, A.; Kernan, N.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Intensified mycophenolate mofetil (MMF) dosing is safe from the standpoint of engraftment and reduces severe acute graft-versus-host disease (aGVHD) after double-unit cord blood transplantation (DCBT): An analysis of 173 patients
    Meeting Abstract

    Ponce, D. M.; Harnicar, S.; Hilden, P.; Devlin, S.; Evans, K.; Lubin, M.; Kernan, N.; Prockop, S. E.; Scaradavou, A.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • High disease-free survival and enhanced protection against relapse after double-unit cord blood transplantation (DCB-T) when compared to unrelated donor transplantation (URD-T) in patients with acute leukemia, MDS and CML
    Meeting Abstract

    Ponce, D. M.; Devlin, S.; Lubin, M.; Maloy, M.; Castro-Malaspina, H.; Goldberg, J. D.; Jakubowski, A. A.; Papadopoulos, E.; Perales, M. A.; Sauter, C.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Reduced intensity conditioning allogeneic stem cell transplantation for adults with relapsed and refractory mantle cell lymphoma: A single center retrospective analysis in the rituximab era
    Meeting Abstract

    Mussetti, A.; Devlin, S.; Castro-Malaspina, H.; Barker, J. N.; Giralt, S. A.; Sauter, C.; Perales, M. A.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • T-cell depleted allogeneic HSCT for patients with relapsed, high-risk multiple myeloma permits long-lasting remissions in the absence of graft-versus-host disease and provides a platform for adoptive immunotherapeutic approaches
    Meeting Abstract

    Koehne, G.; Devlin, S.; Landau, H.; Hassoun, H.; Lesokhin, A. M.; Lendvai, N.; Chung, D. J.; Bravo, C.; Giralt, S. A.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Safety and efficiency of administering foscarnet in an intensive adult bone marrow transplant clinic: A multidisciplinary approach
    Meeting Abstract

    Kenny, S.; Jackson, L.; Coffey, G.; Eaton, A. A.; Giralt, S.; Barker, J. N.; Harnicar, S.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Prospective PCR monitoring reveals adenovirus (ADV) viremia is associated with a significant risk of ADV disease in T-cell depleted and cord blood allograft recipients
    Meeting Abstract

    Huang, Y. T.; Lee, Y. J.; Kolitsopoulos, Y.; Foldi, J.; Seo, S. K.; Giralt, S. A.; Barker, J. N.; Jakubowski, A. A.; Papanicolaou, G.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Do patients with high risk or relapsed core binding factor acute myeloid leukemia benefit from salvage allogeneic stem cell transplantation?
    Meeting Abstract

    Hobbs, G.; Kishtagari, A.; Hilden, P.; Barker, J. N.; Jakubowski, A. A.; Papadopoulos, E.; Devlin, S.; Boulad, F.; Kernan, N.; Kobos, R.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • A novel reduced intensity conditioning regimen for patients with high risk hematologic malignancies undergoing conventional allogeneic stem cell transplantation
    Meeting Abstract

    Hobbs, G.; Kaur, N.; Ponce, D. M.; Hilden, P.; Castro-Malaspina, H.; Giralt, S. A.; Goldberg, J. D.; Papadopoulos, E.; Jakubowski, A. A.; Sauter, C. S.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Phase I/II study of paclitaxel plus ifosfamide followed by high-dose paclitaxel, ifosfamide, and carboplatin with autologous stem cell reinfusion for salvage treatment of germ cell tumors
    Meeting Abstract

    Feldman, D. R.; Glezerman, I.; Patil, S.; Van Alstine, L.; Bajorin, D. F.; Fischer, P.; Hughes, A.; Sheinfeld, J.; Bains, M.; Reich, L.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save